Page 3 - Vstm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Ben Glickman Verastem Oncology named Dan Calkins as its next chief financial officer. The Boston-based biopharmaceutical company said on Thursday that...

StockNews.com cut shares of Verastem (NASDAQ:VSTM – Free Report) from a hold rating to a sell rating in a research report report published on Wednesday. Several other equities research analysts have also issued reports on VSTM. B. Riley assumed coverage on shares of Verastem in a research report on Wednesday, September 27th. They set a […]

StockNews.com upgraded shares of Verastem (NASDAQ:VSTM – Free Report) from a sell rating to a hold rating in a report issued on Tuesday. A number of other equities analysts have also recently weighed in on the company. Cantor Fitzgerald increased their price target on Verastem from $3.00 to $34.00 in a report on Monday, June […]

StockNews.com cut shares of Verastem (NASDAQ:VSTM – Free Report) from a hold rating to a sell rating in a research report report published on Wednesday morning. VSTM has been the subject of a number of other reports. Cantor Fitzgerald raised their price objective on shares of Verastem from $3.00 to $34.00 in a research report […]

Verastem, Inc. (NASDAQ:VSTM – Get Free Report) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 398,200 shares, a growth of 64.8% from the July 15th total of 241,600 shares. Based on an average trading volume of 387,800 shares, the […]